Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Tender offer for hybrid capital securities – final results
Tender offer for hybrid capital securities – final results
Tender offer for hybrid capital securities – final results
E15VC Announces First Close of its Third Fund  with the Continued Support from Sun Hung Kai & Co
E15VC Announces First Close of its Third Fund with the Continued Support from Sun Hung Kai & Co
E15VC Announces First Close of its Third Fund with the Continued Support from Sun Hung Kai & Co
EQS-News: Elmos Semiconductor SE to be included in the SDAX
EQS-News: Elmos Semiconductor SE to be included in the SDAX
EQS-News: Elmos Semiconductor SE to be included in the SDAX
Arix to Present at Mello Investment Trusts & Funds
Arix to Present at Mello Investment Trusts & Funds
Arix to Present at Mello Investment Trusts & Funds
EQS-News: Defence Therapeutics Inc.: DEFENCE POSITIONED TO BEGIN ITS ANTI-CANCER ACCUTOXTM PHASE I TRIAL WITH SUCCESSFUL COMPLETION OF GLP STUDIES
EQS-News: Defence Therapeutics Inc.: DEFENCE POSITIONED TO BEGIN ITS ANTI-CANCER ACCUTOXTM PHASE I TRIAL WITH SUCCESSFUL COMPLETION OF GLP STUDIES
EQS-News: Defence Therapeutics Inc.: DEFENCE POSITIONED TO BEGIN ITS ANTI-CANCER ACCUTOXTM PHASE I TRIAL WITH SUCCESSFUL COMPLETION OF GLP STUDIES
Schaffner Group delivers successful fiscal 2021/22
Schaffner Group delivers successful fiscal 2021/22
Schaffner Group delivers successful fiscal 2021/22
Arbonia continues to strengthen HVAC sales position in Spain and Portugal
Arbonia continues to strengthen HVAC sales position in Spain and Portugal
Arbonia continues to strengthen HVAC sales position in Spain and Portugal
Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5
Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5
Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5
Investor Day for knowledge transfer and information about TX Group’s strategic direction
Investor Day for knowledge transfer and information about TX Group’s strategic direction
Investor Day for knowledge transfer and information about TX Group’s strategic direction
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4): https://mms.businesswire.com/media/20191106005906/en/305625/5/puma_logo_JPEG.jpg
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)


Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on December 3, 2022, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement

Pershing Square Holdings, Ltd. Releases Date of Annual London Investor Presentation: https://mms.businesswire.com/media/20210511006122/en/713603/5/pershing-square-holdings.jpg
Pershing Square Holdings, Ltd. Releases Date of Annual London Investor Presentation


Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (NA:PSH) (the “Company”) today announced that it will hold its annual PSH Investor Presentation on 9 February 2023 at 15:00 GMT (10:00 EST).



Any

Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4): https://mms.businesswire.com/media/20191107005278/en/707846/5/Aurinia-logo-web-700px.jpg
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, announced that

UBS Advisor Team FTB Financial Services Named to the Forbes America’s Top Wealth Management Teams list: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23977/300px-UBS_Logo_SVG.svg.png
UBS Advisor Team FTB Financial Services Named to the Forbes America’s Top Wealth Management Teams list


UBS Wealth Management USA announced today that FTB Financial Services, a wealth management team in the firm’s Kenwood, Ohio branch has been named to the Forbes America’s Top Wealth Management Teams

American Express Relaunches Leadership Academy in Partnership With Common Purpose, TED Foundation, and Taproot Foundationhttp://upload.wikimedia.org/wikipedia/commons/3/30/American_Express_logo.svg: By CoolKid1993 at en.wikipedia. Later version(s) were uploaded by Tkgd2007 at en.wikipedia. [Public domain], from Wikimedia Commons
American Express Relaunches Leadership Academy in Partnership With Common Purpose, TED Foundation, and Taproot Foundation


American Express (NYSE: AXP) today announced the return of its American Express Leadership Academy, with a new curriculum to help nonprofit leaders innovate and meet the rapidly-changing needs of

Acticor Biotech Receives European Medicines Agency (EMA) Endorsement on Key Parameters of ACTISAVE, Its Pivotal Phase II/III Study for Registration in Stroke: https://mms.businesswire.com/media/20220330005534/en/1304115/5/Acticor_Biotech.jpg
Acticor Biotech Receives European Medicines Agency (EMA) Endorsement on Key Parameters of ACTISAVE, Its Pivotal Phase II/III Study for Registration in Stroke


Regulatory News:



Acticor Biotech, (ISIN: FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of

NTT DATA Named a Top Employer for LGBTQ+ Inclusion in India and Mexico: https://mms.businesswire.com/media/20200901005792/en/817545/5/NTT-DATA-Logo-HumanBlue.jpg
NTT DATA Named a Top Employer for LGBTQ+ Inclusion in India and Mexico


NTT DATA, a global digital business and IT services leader, announced today it has been named a 2022 Top Employer by the India Workplace Equality Index (IWEI) and an LGBTQ+ 2023 Best Place to Work

Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
GEVELOT S.A.: Weekly report of share buyback December 5, 2022
GEVELOT S.A.: Weekly report of share buyback December 5, 2022
GEVELOT S.A.: Weekly report of share buyback December 5, 2022
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Chelverton UK Dividend Trust plc: Net Asset Value(s) - REPLACEMENT
Chelverton UK Dividend Trust plc: Net Asset Value(s) - REPLACEMENT
Chelverton UK Dividend Trust plc: Net Asset Value(s) - REPLACEMENT
Eurofins Launches BQ.1 and BQ.1.1 Droplet Digital PCR Assay (ddPCR) for SARS-CoV-2 Wastewater Testing: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg
Eurofins Launches BQ.1 and BQ.1.1 Droplet Digital PCR Assay (ddPCR) for SARS-CoV-2 Wastewater Testing


Eurofins Environment Testing Northern California: Wastewater (EWW) and Eurofins Pandemic Prevention Services (EPPS) today launched a droplet digital PCR (ddPCR) assay for the combined quantitative

Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Humana CEO recognized as one of Modern Healthcare’s 100 Most Influential People in Healthcare: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana CEO recognized as one of Modern Healthcare’s 100 Most Influential People in Healthcare


Humana Inc. (NYSE: HUM) is proud to announce that Bruce D. Broussard, President and Chief Executive Officer, is recognized by Modern Healthcare as one of the 100 Most Influential People in

Groupon to Participate in the Barclays Global Technology, Media & Telecommunications Conference: https://mms.businesswire.com/media/20191104006028/en/466257/5/wordmark_one_cmyk.jpg
Groupon to Participate in the Barclays Global Technology, Media & Telecommunications Conference


Groupon, Inc. (NASDAQ: GRPN) announced that Kedar Deshpande, Chief Executive Officer, and Damien Schmitz, Chief Financial Officer, will participate in the Barclays Global Technology, Media &amp